News

GVK Bio, the global Contract Research and Development Organisation (CRDO), announces that a crescendo of market conditions and a strong customer pipeline are colliding to deliver strong growth in 2020. In the past few years the company has quickly consolidated...

Signant Health is proud to host its 8th annual eCOA Forum, which convenes clinical operations and outcomes research leaders for the industry’s premier event focused on eCOA, eConsent, and patient-centric technology. Held at Philadelphia’s Franklin Institute on December 10-11,...

CPhI Worldwide – the world’s largest pharma event, taking place in Frankfurt, Germany (5-7 November, 2019) – releases the second part of its annual report focussed on biologicals. Fittingly, in 2019 BioProduction – which features five concurrent streams of content...

Catalent, a global leader in clinical supply services, announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled “ Cell and Gene Therapy Logistics ” at the upcoming...

Worldwide Flight Services (WFS) has become the first air cargo handling company in South Africa to be awarded Good Distribution Practice (GDP) certifications for its temperature controlled pharma facilities, aligned to ISO9001:2015, in Johannesburg and Cape Town. This latest WFS...

Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced that the Phase 1a solid tumor trial exploring the safety and tolerability of AVID200, a first-in-class TGF-beta 1 & 3 selective inhibitor, administered as...

Roche said that the phase 3 PEMPHIX trial of MabThera (rituximab) in moderate to severe pemphigus vulgaris (PV) met its primary endpoint at Week 52. The PEMPHIX trial also showed that MabThera was superior to mycophenolate mofetil (MMF) in the...